Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee backs bill to require insurers to cover continuous glucose monitors earlier for some patients
Summary
House Bill 947 would require coverage of continuous glucose monitors (CGMs) for medically necessary cases before patients advance to insulin therapy, a move sponsors and several informational witnesses argued could save money and improve care; insurers present signaled no state defrayal liability.
Representative Fiona Nave introduced HB947, which would require insurers to cover continuous glucose monitors (CGMs) for eligible type 1 and type 2 diabetes patients when medically necessary rather than waiting until the patient is insulin-dependent. Nave described CGMs as a tool that samples glucose every five minutes, provides alarms…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
